Patrick D. Kirwin, Director at ProMIS Neurosciences Inc. (PMN), bought 10,000 shares at $1.25 ($13K) on 2024-08-14, disclosed to the SEC on 2024-08-16.
Open-market purchase of $12k PMN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| PMN | BUY | 2022-12-13 | $5K | — | Filing → |
| PMN | BUY | 2022-08-18 | $24K | — | Filing → |